We found that the growth ability of CML K-562 cells was significantly inhibited after downregulation of UNC13B. To clarify the underlying mechanism, we investigated changes in relevant regulatory molecules in K-562 cells. This evidence concerns the gene UNC13B and chronic myelogenous leukemia, BCR-ABL1 positive.